An F Q, Matsuda M, Fujii H, Matsumoto Y
First Department of Surgery, Yamanashi Medical University, Japan.
J Cancer Res Clin Oncol. 2000 Mar;126(3):153-60. doi: 10.1007/s004320050025.
Vascular endothelial growth factor (VEGF) has been reported to play an important role in angiogenesis in hepatocellular carcinoma (HCC). However, there is great variation in reports on the distribution of VEGF expression, especially in non-carcinoma liver cells. Furthermore, some reports have mentioned that endothelial cells were positive for VEGF antibody but have not evaluated its significance. In this study, we focused our attention to these problems and try to solve them. We also analyzed the factors influencing VEGF expression and evaluated the prognostic potential of VEGF protein in HCC.
We examined the VEGF expression in specimens surgically removed from 46 HCC patients and 3 patients with liver cancer metastatic from the colon, and in 4 specimens of liver tissue with benign disease, by immunohistochemical methods.
RESULTS/CONCLUSIONS: VEGF was expressed in HCC cells and hepatocytes and on vascular endothelial cells. Our finding that about seven times more endothelial cells were positive for VEGF antibody in carcinoma areas than in non-carcinoma areas (P < 0.001) suggests that VEGF is a very important angiogenesis factor for HCC growth. VEGF expression in HCC cells and non-carcinoma liver cells and on endothelial cells did not closely correlate with the disease recurrence rate (P > 0.05), suggesting that VEGF expression may not be useful as an individual factor for estimating the prognosis of HCC. A statistical analysis of the relationships between VEGF expression and clinicopathological variables revealed the following: preoperative transcatheter arterial embolization enhanced VEGF expression in both HCC cells and non-carcinoma liver cells. The histological grade of HCC and the level of alanine aminotransferase was related to VEGF expression in non-carcinoma liver cells and on endothelial cells in HCC areas. Tumor size and the histological status of the accompanying chronic hepatitis also influenced the VEGF expression on endothelial cells. Our findings concerning not only HCC but also the surrounding liver and endothelial cells may provide useful information for further research on the role of VEGF expression in HCC patients.
据报道,血管内皮生长因子(VEGF)在肝细胞癌(HCC)的血管生成中起重要作用。然而,关于VEGF表达分布的报道存在很大差异,尤其是在非癌性肝细胞中。此外,一些报道提到内皮细胞对VEGF抗体呈阳性,但未评估其意义。在本研究中,我们关注这些问题并试图解决它们。我们还分析了影响VEGF表达的因素,并评估了VEGF蛋白在HCC中的预后潜力。
我们通过免疫组织化学方法检测了46例HCC患者和3例结肠癌肝转移患者手术切除标本以及4例良性肝病肝组织标本中的VEGF表达。
结果/结论:VEGF在HCC细胞、肝细胞以及血管内皮细胞中均有表达。我们发现癌区VEGF抗体阳性的内皮细胞数量是非癌区的约7倍(P < 0.001),这表明VEGF是HCC生长的非常重要的血管生成因子。HCC细胞、非癌性肝细胞以及内皮细胞中的VEGF表达与疾病复发率无密切相关性(P > 0.05),这表明VEGF表达可能不能作为评估HCC预后的独立因素。对VEGF表达与临床病理变量之间关系的统计分析显示:术前经导管动脉栓塞增强了HCC细胞和非癌性肝细胞中的VEGF表达。HCC的组织学分级和丙氨酸转氨酶水平与非癌性肝细胞以及HCC区域内皮细胞中的VEGF表达有关。肿瘤大小和伴随慢性肝炎的组织学状态也影响内皮细胞上的VEGF表达。我们不仅关于HCC,而且关于周围肝脏和内皮细胞的发现可能为进一步研究VEGF表达在HCC患者中的作用提供有用信息。